Global GLP-1 Drugs Market Growth 2024-2030

November 2024 | 101 pages | ID: G98866ABAD2FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

GLP-1drugs,also known as GLP-1 receptor agonists,which mimic the action of GLP-1 by binding to GLP-1 receptors on pancreatic beta cells,promoting insulin release and reducing glucagon secretion.This helps lower blood sugar levels after meals,leading to improved glycemic controlIn addition to their glucose-lowering effects,GLP-1 receptor agonists have been shown to promote weight loss and may have cardiovascular benefits.

The global GLP-1 Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Drugs Industry Forecast” looks at past sales and reviews total world GLP-1 Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected GLP-1 Drugs sales for 2024 through 2030. With GLP-1 Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Drugs industry.

This Insight Report provides a comprehensive analysis of the global GLP-1 Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Drugs.

United States market for GLP-1 Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for GLP-1 Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for GLP-1 Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key GLP-1 Drugs players cover Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Dulaglutide
• Exenatide
• Liraglutide
• Lixisenatide
• Semaglutide
• Beinaglutide
• Albiglutide

Segmentation by Application:

• Type 2 Diabetes
• Obesity

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• Eli Lilly
• AstraZeneca
• Sanofi
• GSK
• Shanghai Renhui Biopharmaceutical
• Huadong Medicine
• Sino Biopharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global GLP-1 Drugs market?

What factors are driving GLP-1 Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do GLP-1 Drugs market opportunities vary by end market size?

How does GLP-1 Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global GLP-1 Drugs Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for GLP-1 Drugs by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for GLP-1 Drugs by Country/Region, 2019, 2023 & 2030
2.2 GLP-1 Drugs Segment by Type
  2.2.1 Dulaglutide
  2.2.2 Exenatide
  2.2.3 Liraglutide
  2.2.4 Lixisenatide
  2.2.5 Semaglutide
  2.2.6 Beinaglutide
  2.2.7 Albiglutide
2.3 GLP-1 Drugs Sales by Type
  2.3.1 Global GLP-1 Drugs Sales Market Share by Type (2019-2024)
  2.3.2 Global GLP-1 Drugs Revenue and Market Share by Type (2019-2024)
  2.3.3 Global GLP-1 Drugs Sale Price by Type (2019-2024)
2.4 GLP-1 Drugs Segment by Application
  2.4.1 Type 2 Diabetes
  2.4.2 Obesity
2.5 GLP-1 Drugs Sales by Application
  2.5.1 Global GLP-1 Drugs Sale Market Share by Application (2019-2024)
  2.5.2 Global GLP-1 Drugs Revenue and Market Share by Application (2019-2024)
  2.5.3 Global GLP-1 Drugs Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global GLP-1 Drugs Breakdown Data by Company
  3.1.1 Global GLP-1 Drugs Annual Sales by Company (2019-2024)
  3.1.2 Global GLP-1 Drugs Sales Market Share by Company (2019-2024)
3.2 Global GLP-1 Drugs Annual Revenue by Company (2019-2024)
  3.2.1 Global GLP-1 Drugs Revenue by Company (2019-2024)
  3.2.2 Global GLP-1 Drugs Revenue Market Share by Company (2019-2024)
3.3 Global GLP-1 Drugs Sale Price by Company
3.4 Key Manufacturers GLP-1 Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers GLP-1 Drugs Product Location Distribution
  3.4.2 Players GLP-1 Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GLP-1 DRUGS BY GEOGRAPHIC REGION

4.1 World Historic GLP-1 Drugs Market Size by Geographic Region (2019-2024)
  4.1.1 Global GLP-1 Drugs Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global GLP-1 Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic GLP-1 Drugs Market Size by Country/Region (2019-2024)
  4.2.1 Global GLP-1 Drugs Annual Sales by Country/Region (2019-2024)
  4.2.2 Global GLP-1 Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas GLP-1 Drugs Sales Growth
4.4 APAC GLP-1 Drugs Sales Growth
4.5 Europe GLP-1 Drugs Sales Growth
4.6 Middle East & Africa GLP-1 Drugs Sales Growth

5 AMERICAS

5.1 Americas GLP-1 Drugs Sales by Country
  5.1.1 Americas GLP-1 Drugs Sales by Country (2019-2024)
  5.1.2 Americas GLP-1 Drugs Revenue by Country (2019-2024)
5.2 Americas GLP-1 Drugs Sales by Type (2019-2024)
5.3 Americas GLP-1 Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC GLP-1 Drugs Sales by Region
  6.1.1 APAC GLP-1 Drugs Sales by Region (2019-2024)
  6.1.2 APAC GLP-1 Drugs Revenue by Region (2019-2024)
6.2 APAC GLP-1 Drugs Sales by Type (2019-2024)
6.3 APAC GLP-1 Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe GLP-1 Drugs by Country
  7.1.1 Europe GLP-1 Drugs Sales by Country (2019-2024)
  7.1.2 Europe GLP-1 Drugs Revenue by Country (2019-2024)
7.2 Europe GLP-1 Drugs Sales by Type (2019-2024)
7.3 Europe GLP-1 Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa GLP-1 Drugs by Country
  8.1.1 Middle East & Africa GLP-1 Drugs Sales by Country (2019-2024)
  8.1.2 Middle East & Africa GLP-1 Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa GLP-1 Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa GLP-1 Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Drugs
10.3 Manufacturing Process Analysis of GLP-1 Drugs
10.4 Industry Chain Structure of GLP-1 Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 GLP-1 Drugs Distributors
11.3 GLP-1 Drugs Customer

12 WORLD FORECAST REVIEW FOR GLP-1 DRUGS BY GEOGRAPHIC REGION

12.1 Global GLP-1 Drugs Market Size Forecast by Region
  12.1.1 Global GLP-1 Drugs Forecast by Region (2025-2030)
  12.1.2 Global GLP-1 Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global GLP-1 Drugs Forecast by Type (2025-2030)
12.7 Global GLP-1 Drugs Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Information
  13.1.2 Novo Nordisk GLP-1 Drugs Product Portfolios and Specifications
  13.1.3 Novo Nordisk GLP-1 Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Novo Nordisk Main Business Overview
  13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
  13.2.1 Eli Lilly Company Information
  13.2.2 Eli Lilly GLP-1 Drugs Product Portfolios and Specifications
  13.2.3 Eli Lilly GLP-1 Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Eli Lilly Main Business Overview
  13.2.5 Eli Lilly Latest Developments
13.3 AstraZeneca
  13.3.1 AstraZeneca Company Information
  13.3.2 AstraZeneca GLP-1 Drugs Product Portfolios and Specifications
  13.3.3 AstraZeneca GLP-1 Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 AstraZeneca Main Business Overview
  13.3.5 AstraZeneca Latest Developments
13.4 Sanofi
  13.4.1 Sanofi Company Information
  13.4.2 Sanofi GLP-1 Drugs Product Portfolios and Specifications
  13.4.3 Sanofi GLP-1 Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Sanofi Main Business Overview
  13.4.5 Sanofi Latest Developments
13.5 GSK
  13.5.1 GSK Company Information
  13.5.2 GSK GLP-1 Drugs Product Portfolios and Specifications
  13.5.3 GSK GLP-1 Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 GSK Main Business Overview
  13.5.5 GSK Latest Developments
13.6 Shanghai Renhui Biopharmaceutical
  13.6.1 Shanghai Renhui Biopharmaceutical Company Information
  13.6.2 Shanghai Renhui Biopharmaceutical GLP-1 Drugs Product Portfolios and Specifications
  13.6.3 Shanghai Renhui Biopharmaceutical GLP-1 Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Shanghai Renhui Biopharmaceutical Main Business Overview
  13.6.5 Shanghai Renhui Biopharmaceutical Latest Developments
13.7 Huadong Medicine
  13.7.1 Huadong Medicine Company Information
  13.7.2 Huadong Medicine GLP-1 Drugs Product Portfolios and Specifications
  13.7.3 Huadong Medicine GLP-1 Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Huadong Medicine Main Business Overview
  13.7.5 Huadong Medicine Latest Developments
13.8 Sino Biopharm
  13.8.1 Sino Biopharm Company Information
  13.8.2 Sino Biopharm GLP-1 Drugs Product Portfolios and Specifications
  13.8.3 Sino Biopharm GLP-1 Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Sino Biopharm Main Business Overview
  13.8.5 Sino Biopharm Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. GLP-1 Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. GLP-1 Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Dulaglutide
Table 4. Major Players of Exenatide
Table 5. Major Players of Liraglutide
Table 6. Major Players of Lixisenatide
Table 7. Major Players of Semaglutide
Table 8. Major Players of Beinaglutide
Table 9. Major Players of Albiglutide
Table 10. Global GLP-1 Drugs Sales byType (2019-2024) & (K Units)
Table 11. Global GLP-1 Drugs Sales Market Share byType (2019-2024)
Table 12. Global GLP-1 Drugs Revenue byType (2019-2024) & ($ million)
Table 13. Global GLP-1 Drugs Revenue Market Share byType (2019-2024)
Table 14. Global GLP-1 Drugs Sale Price byType (2019-2024) & (US$/Unit)
Table 15. Global GLP-1 Drugs Sale by Application (2019-2024) & (K Units)
Table 16. Global GLP-1 Drugs Sale Market Share by Application (2019-2024)
Table 17. Global GLP-1 Drugs Revenue by Application (2019-2024) & ($ million)
Table 18. Global GLP-1 Drugs Revenue Market Share by Application (2019-2024)
Table 19. Global GLP-1 Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 20. Global GLP-1 Drugs Sales by Company (2019-2024) & (K Units)
Table 21. Global GLP-1 Drugs Sales Market Share by Company (2019-2024)
Table 22. Global GLP-1 Drugs Revenue by Company (2019-2024) & ($ millions)
Table 23. Global GLP-1 Drugs Revenue Market Share by Company (2019-2024)
Table 24. Global GLP-1 Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 25. Key Manufacturers GLP-1 Drugs Producing Area Distribution and Sales Area
Table 26. Players GLP-1 Drugs Products Offered
Table 27. GLP-1 Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Market M&A Activity & Strategy
Table 30. Global GLP-1 Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 31. Global GLP-1 Drugs Sales Market Share Geographic Region (2019-2024)
Table 32. Global GLP-1 Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global GLP-1 Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global GLP-1 Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 35. Global GLP-1 Drugs Sales Market Share by Country/Region (2019-2024)
Table 36. Global GLP-1 Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global GLP-1 Drugs Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas GLP-1 Drugs Sales by Country (2019-2024) & (K Units)
Table 39. Americas GLP-1 Drugs Sales Market Share by Country (2019-2024)
Table 40. Americas GLP-1 Drugs Revenue by Country (2019-2024) & ($ millions)
Table 41. Americas GLP-1 Drugs Sales byType (2019-2024) & (K Units)
Table 42. Americas GLP-1 Drugs Sales by Application (2019-2024) & (K Units)
Table 43. APAC GLP-1 Drugs Sales by Region (2019-2024) & (K Units)
Table 44. APAC GLP-1 Drugs Sales Market Share by Region (2019-2024)
Table 45. APAC GLP-1 Drugs Revenue by Region (2019-2024) & ($ millions)
Table 46. APAC GLP-1 Drugs Sales byType (2019-2024) & (K Units)
Table 47. APAC GLP-1 Drugs Sales by Application (2019-2024) & (K Units)
Table 48. Europe GLP-1 Drugs Sales by Country (2019-2024) & (K Units)
Table 49. Europe GLP-1 Drugs Revenue by Country (2019-2024) & ($ millions)
Table 50. Europe GLP-1 Drugs Sales byType (2019-2024) & (K Units)
Table 51. Europe GLP-1 Drugs Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa GLP-1 Drugs Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa GLP-1 Drugs Revenue Market Share by Country (2019-2024)
Table 54. Middle East & Africa GLP-1 Drugs Sales byType (2019-2024) & (K Units)
Table 55. Middle East & Africa GLP-1 Drugs Sales by Application (2019-2024) & (K Units)
Table 56. Key Market Drivers & Growth Opportunities of GLP-1 Drugs
Table 57. Key Market Challenges & Risks of GLP-1 Drugs
Table 58. Key IndustryTrends of GLP-1 Drugs
Table 59. GLP-1 Drugs Raw Material
Table 60. Key Suppliers of Raw Materials
Table 61. GLP-1 Drugs Distributors List
Table 62. GLP-1 Drugs Customer List
Table 63. Global GLP-1 Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 64. Global GLP-1 Drugs RevenueForecast by Region (2025-2030) & ($ millions)
Table 65. Americas GLP-1 Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 66. Americas GLP-1 Drugs Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 67. APAC GLP-1 Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 68. APAC GLP-1 Drugs Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 69. Europe GLP-1 Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 70. Europe GLP-1 Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Middle East & Africa GLP-1 Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 72. Middle East & Africa GLP-1 Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 73. Global GLP-1 Drugs SalesForecast byType (2025-2030) & (K Units)
Table 74. Global GLP-1 Drugs RevenueForecast byType (2025-2030) & ($ millions)
Table 75. Global GLP-1 Drugs SalesForecast by Application (2025-2030) & (K Units)
Table 76. Global GLP-1 Drugs RevenueForecast by Application (2025-2030) & ($ millions)
Table 77. Novo Nordisk Basic Information, GLP-1 Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Novo Nordisk GLP-1 Drugs Product Portfolios and Specifications
Table 79. Novo Nordisk GLP-1 Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Novo Nordisk Main Business
Table 81. Novo Nordisk Latest Developments
Table 82. Eli Lilly Basic Information, GLP-1 Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Eli Lilly GLP-1 Drugs Product Portfolios and Specifications
Table 84. Eli Lilly GLP-1 Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Eli Lilly Main Business
Table 86. Eli Lilly Latest Developments
Table 87. AstraZeneca Basic Information, GLP-1 Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca GLP-1 Drugs Product Portfolios and Specifications
Table 89. AstraZeneca GLP-1 Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Latest Developments
Table 92. Sanofi Basic Information, GLP-1 Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi GLP-1 Drugs Product Portfolios and Specifications
Table 94. Sanofi GLP-1 Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. GSK Basic Information, GLP-1 Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK GLP-1 Drugs Product Portfolios and Specifications
Table 99. GSK GLP-1 Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Shanghai Renhui Biopharmaceutical Basic Information, GLP-1 Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai Renhui Biopharmaceutical GLP-1 Drugs Product Portfolios and Specifications
Table 104. Shanghai Renhui Biopharmaceutical GLP-1 Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Shanghai Renhui Biopharmaceutical Main Business
Table 106. Shanghai Renhui Biopharmaceutical Latest Developments
Table 107. Huadong Medicine Basic Information, GLP-1 Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Huadong Medicine GLP-1 Drugs Product Portfolios and Specifications
Table 109. Huadong Medicine GLP-1 Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Huadong Medicine Main Business
Table 111. Huadong Medicine Latest Developments
Table 112. Sino Biopharm Basic Information, GLP-1 Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Sino Biopharm GLP-1 Drugs Product Portfolios and Specifications
Table 114. Sino Biopharm GLP-1 Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Sino Biopharm Main Business
Table 116. Sino Biopharm Latest Developments



LIST OFFIGURES

Figure 1. Picture of GLP-1 Drugs
Figure 2. GLP-1 Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global GLP-1 Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. GLP-1 Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. GLP-1 Drugs Sales Market Share by Country/Region (2023)
Figure 10. GLP-1 Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Dulaglutide
Figure 12. Product Picture of Exenatide
Figure 13. Product Picture of Liraglutide
Figure 14. Product Picture of Lixisenatide
Figure 15. Product Picture of Semaglutide
Figure 16. Product Picture of Beinaglutide
Figure 17. Product Picture of Albiglutide
Figure 18. Global GLP-1 Drugs Sales Market Share byType in 2023
Figure 19. Global GLP-1 Drugs Revenue Market Share byType (2019-2024)
Figure 20. GLP-1 Drugs Consumed inType 2 Diabetes
Figure 21. Global GLP-1 Drugs Market:Type 2 Diabetes (2019-2024) & (K Units)
Figure 22. GLP-1 Drugs Consumed in Obesity
Figure 23. Global GLP-1 Drugs Market: Obesity (2019-2024) & (K Units)
Figure 24. Global GLP-1 Drugs Sale Market Share by Application (2023)
Figure 25. Global GLP-1 Drugs Revenue Market Share by Application in 2023
Figure 26. GLP-1 Drugs Sales by Company in 2023 (K Units)
Figure 27. Global GLP-1 Drugs Sales Market Share by Company in 2023
Figure 28. GLP-1 Drugs Revenue by Company in 2023 ($ millions)
Figure 29. Global GLP-1 Drugs Revenue Market Share by Company in 2023
Figure 30. Global GLP-1 Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global GLP-1 Drugs Revenue Market Share by Geographic Region in 2023
Figure 32. Americas GLP-1 Drugs Sales 2019-2024 (K Units)
Figure 33. Americas GLP-1 Drugs Revenue 2019-2024 ($ millions)
Figure 34. APAC GLP-1 Drugs Sales 2019-2024 (K Units)
Figure 35. APAC GLP-1 Drugs Revenue 2019-2024 ($ millions)
Figure 36. Europe GLP-1 Drugs Sales 2019-2024 (K Units)
Figure 37. Europe GLP-1 Drugs Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa GLP-1 Drugs Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa GLP-1 Drugs Revenue 2019-2024 ($ millions)
Figure 40. Americas GLP-1 Drugs Sales Market Share by Country in 2023
Figure 41. Americas GLP-1 Drugs Revenue Market Share by Country (2019-2024)
Figure 42. Americas GLP-1 Drugs Sales Market Share byType (2019-2024)
Figure 43. Americas GLP-1 Drugs Sales Market Share by Application (2019-2024)
Figure 44. United States GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC GLP-1 Drugs Sales Market Share by Region in 2023
Figure 49. APAC GLP-1 Drugs Revenue Market Share by Region (2019-2024)
Figure 50. APAC GLP-1 Drugs Sales Market Share byType (2019-2024)
Figure 51. APAC GLP-1 Drugs Sales Market Share by Application (2019-2024)
Figure 52. China GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. India GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. ChinaTaiwan GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe GLP-1 Drugs Sales Market Share by Country in 2023
Figure 60. Europe GLP-1 Drugs Revenue Market Share by Country (2019-2024)
Figure 61. Europe GLP-1 Drugs Sales Market Share byType (2019-2024)
Figure 62. Europe GLP-1 Drugs Sales Market Share by Application (2019-2024)
Figure 63. Germany GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64.France GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. UK GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa GLP-1 Drugs Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa GLP-1 Drugs Sales Market Share byType (2019-2024)
Figure 70. Middle East & Africa GLP-1 Drugs Sales Market Share by Application (2019-2024)
Figure 71. Egypt GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74.Turkey GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries GLP-1 Drugs Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of GLP-1 Drugs in 2023
Figure 77. Manufacturing Process Analysis of GLP-1 Drugs
Figure 78. Industry Chain Structure of GLP-1 Drugs
Figure 79. Channels of Distribution
Figure 80. Global GLP-1 Drugs Sales MarketForecast by Region (2025-2030)
Figure 81. Global GLP-1 Drugs Revenue Market ShareForecast by Region (2025-2030)
Figure 82. Global GLP-1 Drugs Sales Market ShareForecast byType (2025-2030)
Figure 83. Global GLP-1 Drugs Revenue Market ShareForecast byType (2025-2030)
Figure 84. Global GLP-1 Drugs Sales Market ShareForecast by Application (2025-2030)
Figure 85. Global GLP-1 Drugs Revenue Market ShareForecast by Application (2025-2030)